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A 48-year-old man with myeloma was treated initially with dexamethasone and lenalidomide. He subsequently underwent autologous peripheral blood SCT (PSCT). A preparative regimen of melphalan 200 mg/m 2 was given starting on day À4 before stem cell infusion. Initial laboratory values showed a WBC count of 5.5 Â 10 6 per liter, Hb of 9.2 g per 100 ml and plt count of 429 Â 10 9 per liter. His blood work was monitored daily. On day þ 3 of PSCT, he became neutropenic and was started on oral antibiotics in addition to his prophylactic regimen of fluconazole and acyclovir. His WBC count that day was 0.5 Â 10 6 per liter, Hb 8.5 g per 100 ml and plt count 140 Â 10 9 per liter. On account of fever, his antibiotics were changed from oral ciprofloxacin to i.v. cefepime. On day þ 5 of PSCT, fluconazole was replaced by voriconazole when his neutropenic fevers continued. On day þ 7 of PSCT, the patient complained of blurry vision. As voriconazole can be associated with visual disturbances, it was discontinued. The peripheral vision was worse than central. An ophthalmological examination confirmed that he had bitemporal hemianopsia. The plt count that day was 9 Â 10 9 per liter, and he was transfused plts. Before this event, the patient's plt count had been above 15 Â 10 9 per liter, the cutoff necessary for plt transfusions at our institution. His coagulation profile was normal. Computed tomography scan of the brain revealed a 2.3 Â 2.5 cm hemorrhagic pituitary mass. The patient was supported with additional plt transfusions in conjunction with hydrocortisone. Our goal was to keep the plt count over 75 Â 10 9 per liter. He developed diabetes insipidus and required desmopressin. Magnetic resonance imaging of the brain confirmed a large suprasellar mass consistent with a pituitary macroadenoma that contained hemorrhage ( Figure 1 ).
Owing to his neutropenia, trans-sphenoidal resection was delayed. He was managed conservatively until his ANC was greater than 0.5 Â 10 6 per liter. He continued to experience diplopia concomitant with bitemporal hemianopsia, but his visual deficits did not progress during the period of pancytopenia. Trans-sphenoidal surgery was performed nine days after neutrophil engraftment. Pathology showed anterior pituitary tissue with acute hemorrhage consistent with pituitary apoplexy. Congo red stain for amyloid was negative. At 1-year follow-up after PSCT, his visual deficits had resolved, but he continued to have symptoms of diabetes insipidus.
The incidence of pituitary apoplexy is variable, and has reportedly been as high as 25% in patients with pituitary adenoma. 2 Most patients have non-functional adenomas and are asymptomatic. Although the clinical presentation is variable, common symptoms include headache, nausea and visual deficits. 2, 3 This patient experienced bitemporal hemianopsia, a common deficit, as the optic chiasm is vulnerable to stretching by a growing adenoma.
Various factors have been identified as precipitating causes of pituitary apoplexy. They include acute changes in blood flow to the pituitary, stimulation of the pituitary gland and impaired coagulation.
3,4 Impaired coagulation states include patients who were anticoagulated for unstable angina or patients who were thrombocytopenic. 5, 6 All patients undergoing PSCT become thrombocytopenic secondary to the preparative regimen given before transplant and may be at increased risk for this complication.
Once apoplexy occurs, morbidity is decreased with prompt identification and treatment of hypopituitarism. Neuro-ophthalmic complications can be managed with surgical or conservative medical intervention. Retrospective reviews have not shown significant differences between conservative medical and surgical intervention. 7, 8 Emergent surgery is indicated for those with deteriorating vision, hemiparesis or altered mental status, whereas those with stable or resolving visual field deficits could be managed conservatively. 7 One retrospective study has suggested that prompt surgical intervention within 8 days of diagnosis may improve visual defect recovery. 9 Surgical management of pancytopenic patients may be delayed for lengthy periods depending on count recovery. This may affect the overall benefit of surgical intervention in this population. 
